Literature DB >> 16052533

A signal achievement in the treatment of arthritis.

Randy Q Cron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16052533     DOI： 10.1002/art.21206

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  6 in total

1.  A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis.

Authors:  Carol A Langford; David Cuthbertson; Steven R Ytterberg; Nader Khalidi; Paul A Monach; Simon Carette; Philip Seo; Larry W Moreland; Michael Weisman; Curry L Koening; Antoine G Sreih; Robert Spiera; Carol A McAlear; Kenneth J Warrington; Christian Pagnoux; Kathleen McKinnon; Lindsy J Forbess; Gary S Hoffman; Renée Borchin; Jeffrey P Krischer; Peter A Merkel
Journal:  Arthritis Rheumatol       Date:  2017-03-08       Impact factor: 10.995

2.  A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.

Authors:  Carol A Langford; David Cuthbertson; Steven R Ytterberg; Nader Khalidi; Paul A Monach; Simon Carette; Philip Seo; Larry W Moreland; Michael Weisman; Curry L Koening; Antoine G Sreih; Robert Spiera; Carol A McAlear; Kenneth J Warrington; Christian Pagnoux; Kathleen McKinnon; Lindsy J Forbess; Gary S Hoffman; Renée Borchin; Jeffrey P Krischer; Peter A Merkel
Journal:  Arthritis Rheumatol       Date:  2017-03-03       Impact factor: 10.995

Review 3.  Rheumatoid arthritis: advances in treatment strategies.

Authors:  Peeyush Prasad; Sneha Verma; Nirmal Kumar Ganguly; Ved Chaturvedi; Shivani Arora Mittal
Journal:  Mol Cell Biochem       Date:  2022-06-21       Impact factor: 3.396

4.  An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's).

Authors:  Carol A Langford; Paul A Monach; Ulrich Specks; Philip Seo; David Cuthbertson; Carol A McAlear; Steven R Ytterberg; Gary S Hoffman; Jeffrey P Krischer; Peter A Merkel
Journal:  Ann Rheum Dis       Date:  2013-12-09       Impact factor: 19.103

5.  The Development of Novel Therapies for Rheumatoid Arthritis.

Authors:  Ling-Dong Quan; Geoffrey M Thiele; Jun Tian; Dong Wang
Journal:  Expert Opin Ther Pat       Date:  2008-07       Impact factor: 6.674

Review 6.  Treatment of juvenile idiopathic arthritis: a revolution in care.

Authors:  Matthew L Stoll; Randy Q Cron
Journal:  Pediatr Rheumatol Online J       Date:  2014-04-23       Impact factor: 3.054
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.